Drugs / Hewei Anchang Formula
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07715760 | Jan 2027 → Jun 2028 expected | dyspepsia, irritable bowel syndrome | Xiyuan Hospital of China Academy of Chinese Medical Sciences | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hewei Anchang Formula | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07715760 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Hewei Anchang Formula is an optimized herbal formula” NCT07715760 ↗ |
| Route | Oral | “Hewei Anchang Formula granules will be administered orally” NCT07715760 ↗ |